Latest Articles

  • Type of diabetes mellitus: Does it matter to the clinician?
    Byron J. Hoogwerf, MD, FACP, FACE
    Cleveland Clinic Journal of Medicine February 2020, 87 (2) 100-108; DOI: https://doi.org/10.3949/ccjm.87a.19020

    Understanding the many faces of diabetes can make a difference in how clinicians select glucose-lowering therapy.

  • Correction
    Cleveland Clinic Journal of Medicine February 2020, 87 (2) 79;

    The article, “Fever in a traveler returning from Ethiopia,” by Ken Koon Wong, MD (Cleve Clin J Med 2020; 87(1):31–42; doi:10.3949/ccjm.87a.19017) contained an error in Table 7.

  • Familial hypercholesterolemia: Detect, treat, and ask about family
    Familial hypercholesterolemia: Detect, treat, and ask about family
    Nishant P. Shah, MD, Haitham M. Ahmed, MD, MPH and W. H. Wilson Tang, MD
    Cleveland Clinic Journal of Medicine February 2020, 87 (2) 109-120; DOI: https://doi.org/10.3949/ccjm.87a.19021

    Patients can develop elevated LDL-C and atherosclerotic cardiovascular disease at a young age.

  • Pharmacogenomics: An evolving clinical tool for precision medicine
    Jennifer K. Hockings, PharmD, PhD, Amy L. Pasternak, PharmD, Angelika L. Erwin, MD, PhD, Neil T. Mason, MBA, Charis Eng, MD, PhD and J. Kevin Hicks, PharmD, PhD
    Cleveland Clinic Journal of Medicine February 2020, 87 (2) 91-99; DOI: https://doi.org/10.3949/ccjm.87a.19073

    More than 90% of patients are thought to carry at least 1 genetic variant that should prompt a change in dosing or medication.

  • In reply: Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
    Sunil Bhandari, MBChB, FRCP, PhD, M Clin Edu, FHEA, Tasnim Momoniat, MBChB, MRCP (UK) and Duha Ilyas, MBBS, MRCP (UK)
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 9-10; DOI: https://doi.org/10.3949/ccjm.87c.01002
  • Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
    Robert Fakheri, MD, Sripal Bangalore, MD and Franz Messerli, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 9; DOI: https://doi.org/10.3949/ccjm.87c.01001
  • How should diabetic dyslipidemia be treated?
    Taher Modarressi, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 11; DOI: https://doi.org/10.3949/ccjm.87c.01003
  • Fever in a traveler returning from Ethiopia
    Ken Koon Wong, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 31-42; DOI: https://doi.org/10.3949/ccjm.87a.19017

    His symptoms began about 10 days after returning and had been going on for 11 days. What was the cause?

  • In reply: How should diabetic dyslipidemia be treated?
    Ting-I Lee, MD, PhD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 11; DOI: https://doi.org/10.3949/ccjm.87c.01004
  • Off-label and oft-prescribed
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 766-767; DOI: https://doi.org/10.3949/ccjm.86b.12019

    When prescribing drugs for uses beyond their FDA indications, we need to explain their anticipated side effects and benefits.

Pages